| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AN2 Therapeutics, Inc. | Chief Operating Officer and Chief Legal Officer | Common Stock | 207,499 | $273,898 | $1.32 | 20 Feb 2026 | Direct |
| AN2 Therapeutics, Inc. | Chief Operating Officer and Chief Legal Officer | Stock Option (right to buy) | 100,000 | 20 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics, Inc. | 20 Feb 2026 | 2 | $0 | 4 | Chief Operating Officer and Chief Legal Officer | 23 Feb 2026, 16:41 |
| ANTX | AN2 Therapeutics, Inc. | 05 Jan 2026 | 2 | -$24,962 | 4 | Chief Operating Officer and Chief Legal Officer | 07 Jan 2026, 20:12 |
| ANTX | AN2 Therapeutics, Inc. | 04 Nov 2025 | 1 | -$3,214 | 4 | Chief Operating Officer and Chief Legal Officer | 06 Nov 2025, 18:12 |
| ANTX | AN2 Therapeutics, Inc. | 26 Feb 2025 | 2 | $0 | 4 | Chief Operating Officer and Chief Legal Officer | 28 Feb 2025, 16:22 |
| ANTX | AN2 Therapeutics, Inc. | 03 Jan 2025 | 1 | -$12,958 | 4 | Chief Operating Officer and Chief Legal Officer | 07 Jan 2025, 19:57 |
| ANTX | AN2 Therapeutics, Inc. | 04 Nov 2024 | 2 | $0 | 4 | Chief Operating Officer and Chief Legal Officer | 05 Nov 2024, 16:51 |
| ANTX | AN2 Therapeutics, Inc. | 10 Jul 2024 | 1 | $0 | 4 | Chief Legal Officer | 12 Jul 2024, 16:13 |
| ANTX | AN2 Therapeutics, Inc. | 15 Mar 2024 | 1 | $0 | 4/A | Chief Legal Officer | 29 Mar 2024, 16:18 |
| ANTX | AN2 Therapeutics, Inc. | 15 Mar 2024 | 2 | $0 | 4 | Chief Legal Officer | 18 Mar 2024, 19:28 |
| ANTX | AN2 Therapeutics, Inc. | 15 Feb 2023 | 1 | $0 | 4 | Chief Legal Officer | 17 Feb 2023, 18:24 |
| ANTX | AN2 Therapeutics, Inc. | 14 Oct 2022 | 1 | $0 | 4 | Chief Legal Officer | 28 Oct 2022, 18:03 |
| ANTX | AN2 Therapeutics, Inc. | 29 Sep 2022 | 0 | $0 | 3 | General Counsel, Chief Legal Officer and Corporate Secretary Exhibit 24 - Power of Attorney | 05 Oct 2022, 18:21 |